维普中文期刊产品整合服务
27篇 您的检索式:作者名="Kane RC"
    题名 作者 年代 出处 被引量
1Bortezomib for the treatment of mantle cell lymphoma 显示文摘Kane RC Dagher R Farrell A I 2007Clin Cancer Res2007,13,181:1
2Sorafenib for the treatment ofadvanced renal cell carcinoma 显示文摘Kane RC Farrell AT Saber H 2006Clin Cancer Res2006,12,:1
3Sorafenib for the treatment of advanced renal cell carcinoma显示文摘Kane RC Farrell AT Saber H 2006Clin Cancer Res2006,12,24:1
4United States Food and Drug Administration Approval Summary: Bortezomib for the Treatment of Progressive Multiple Myeloma after One Prior Therapy 显示文摘Kane RC Farrell AT Sridhara R 2006Clinical Cancer Research2006,12,10:1
5Dexrazoxane(Totect):FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy显示文摘Kane RC Mc Guinn WD Jr Dagher R 2008Oncologist2008,13,4:1
6Studies on the systematics of Phaeoannellomyces werneckii and other medically important dematiaceous fungi显示文摘Kane J Sumol L Lerbell RC 1987J Clin Microb1987,25,3:1
7Use of cyst fluid CEA,CA19-9,and amylase for evaluation of pancreatic lesions显示文摘Snozek CL Mascarenhas RC O'kane DJ 0,,15:1
8Sorafenib for the treatment of advanced renal cell carcinoma显示文摘Kane RC Farrell AT Saber H 2006Clin Cancer Res2006,12,:1
9Bortezomib for the treatment of mantle cell lymphoma显示文摘Kane RC Dagher R Farrell A 2007Clin Cancer Res2007,13,181:1
10Sorafenib for the treatment of advanced renal cell carcinoma 显示文摘KANE RC FARRELL AT SABER H 2006Clin Cancer Res2006,12,24:1
11Sorafenib for the treatment of unresectable hepatocellular carcinoma显示文摘Kane RC Farrell AT Madabushi R 2009Oncologist2009,14,1:1
12Veleade: USFDA approval for the treatment of multiple myeloma progressing on prior therapy 显示文摘Kane RC Bross PF Farrel AT 2003Oncologist2003,8,6:1
13Bortezomib for the treatment of mantle cell lymphoma显示文摘Kane RC Dagher R Farrel A 2007Clin Cancer Res2007,,13:1
14Sorafenib for the treatment of advanced renal cell carcinoma显示文摘Kane RC Farrell AT Saber H 2006Clin Cancer Res2006,12,24:1
15United States Food and Drug Administration approval summary:bortezomib for the treatment of progressive multiple myeloma after one prior therapy显示文摘Kane RC Farrell AT Sridhara R 0,,10:1
16United States Food and Drug Administration approval summary:bortezomib for the treatment of progressive multiple myeloma after one prior therapy显示文摘Kane RC Farrell AT Sridhara R 2006Clin Cancer Res2006,12,10:1
17Trichophyton krajdenii, An anthropophilic dermatophyte显示文摘Kane J Scott JA summerbell RC 1993Mycotaxon1993,45,:1
18Sorafenib for the treatment of advanced renal cell carcinoma 显示文摘Kane RC Farrell AT Saber I-I 2006C lin Cancer Res2006,12,24:1
19Bortezomib for the treatment of mantle cell lymphoma显示文摘Kane RC Dagher R Farrell A 2007Clin Cancer Res2007,13,181:1
20Efficiency and safety of sorafenib显示文摘Kane RC Farrell AT Saber H 2006Clin Cancer Res2006,12,24:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费